QNRX
Quoin Pharmaceuticals, Ltd.
There isn't enough reported data to score QNRX yet.
QNRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
QNRX's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
QNRX PE Valuation
QNRX has no meaningful PE right now: it lost money over the past year.
QNRX Forward outlook
There aren't enough analyst estimates for QNRX to show an outlook.
QNRX Earnings Per Share
QNRX Quarterly Revenue
QNRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.8M | -$3.5M |
| Q2 2026 | -$3.1M | +$542K |
| Q1 2026 | -$4.9M | -$2.3M |
| Q4 2025 | -$5M | -$2.8M |
| Q3 2025 | -$2.2M | -$46.2K |
| Q2 2025 | -$3.7M | -$1.7M |
| Q1 2025 | -$2.6M | -$1.2M |
| Q4 2024 | -$2.2M | +$987.1K |
QNRX has burned cash in almost every quarter: โ$19M over the past year, against โ$11M the year before.
QNRX Net Leverage
QNRX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
QNRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 8.6 | Oversold |
QNRX's weekly RSI is 39 (neutral) and its Stochastic is 9 (oversold).
QNRX PE vs Healthcare Sector
QNRX has no meaningful PE right now: it lost money over the past year.
QNRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.41 | 15% below |
| 20 week MA | $5.00 | 25% below |
| 50 week MA | $6.76 | 45% below |
| 100 week MA | $8.83 | 58% below |
QNRX is in a downtrend: it's below all four of its weekly moving averages, and 58% below its 100-week average.
QNRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $25.9 | $19.3 | -26% |
| 2025 | $19.3 | $14.0 | -27% |
| 2026 YTD | $14.0 | $3.75 | -73% |
QNRX has finished every year since 2024 lower, and it's down 73% so far in 2026.